Unravelling adherence to prophylaxis in haemophilia: a patients' perspective

被引:30
|
作者
Schrijvers, L. H. [1 ]
Kars, M. C. [2 ]
Beijlevelt-van der Zande, M. [3 ]
Peters, M. [3 ]
Schuurmans, M. J. [4 ,5 ]
Fischer, K. [1 ,2 ]
机构
[1] Univ Med Ctr Utrecht, Van Creveldklin, NL-3508 GA Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Haemophilia Treatment Ctr, NL-1105 AZ Amsterdam, Netherlands
[4] Univ Appl Sci, Fac Hlth Care, Nursing Sci, Utrecht, Netherlands
[5] Univ Med Ctr Utrecht, Nursing Sci, NL-3508 GA Utrecht, Netherlands
关键词
barrier; compliance; determinants; haemophilia; qualitative study; treatment; NETHERLANDS; INTERVIEWS; BEHAVIOR; YOUTH;
D O I
10.1111/hae.12660
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Given the lifelong therapy in haemophilia patients, insight in non-adherence behaviour from a patient perspective is important to understand patients' difficulties with the following treatment recommendations. The aim of this study was to clarify the process underlying adherence (behaviour) to prophylactic treatment, from a patients' perspective. To develop a grounded theory, a qualitative study using individual in-depth interviews was performed to understand experiences, perceptions and beliefs concerning adherence to prophylaxis. From two Dutch treatment centres, 21 adults with haemophilia using prophylaxis were interviewed. Patients were asked how they experience their task to administer prophylaxis and how they adhere to this. The interviews were transcribed, coded and analysed in an iterative process, leading to the development of the grounded theory. Adherence was determined by the position of prophylaxis in life. The position of prophylaxis was determined by the perception of prophylaxis and the ability to exert prophylaxis. Patients' perception was influenced by two main factors: acceptance of haemophilia and feeling/fearing symptoms. The ability to exert prophylaxis was influenced by understanding haemophilia and prophylaxis and planning/infusion skills. The combination of different perceptions and skills led to four main positions of prophylaxis in life: (i) prophylaxis integrated in life, (ii) prophylaxis according to doctors' advice, struggling with irregular situations, (iii) prophylaxis is too much to handle, (iv) prophylaxis is a confrontation with illness. The adherence level gradually decreased from position 1 to 4. This information can be used to design tailored interventions to promote adherence.
引用
收藏
页码:612 / 621
页数:10
相关论文
共 50 条
  • [21] Non-adherence to prophylaxis in haemophilia: extent and underlying reason
    Schrijvers, M.
    van der Zande, M. B.
    Peters, M.
    Peters, M.
    Lock, J.
    Cnossen, M.
    Schuurmans, M.
    Fischer, K.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 89 - 89
  • [22] The use of secondary prophylaxis in the haemophilia A patients
    Aydogan, G.
    Sen, H.
    Salcioglu, Z.
    Akici, F.
    Tugcu, D.
    Aycicek, A.
    Gokce, M.
    Bayram, C.
    Keskindemirci, G.
    Ayaz, N. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 853 - 853
  • [23] FEIBA prophylaxis for patients with haemophilia and inhibitors
    Valentino, L. A.
    HAEMOPHILIA, 2006, 12 : 26 - 31
  • [24] Prophylaxis in adult patients with severe haemophilia A
    Oldenburg, Johannes
    Brackmann, Hans-Hermann
    THROMBOSIS RESEARCH, 2014, 134 : S33 - S37
  • [25] Considerations in individualizing prophylaxis in patients with haemophilia A
    Valentino, L. A.
    HAEMOPHILIA, 2014, 20 (05) : 607 - 615
  • [26] Adherence to treatment in patients with haemophilia in Germany
    Miesbach, W.
    Kalnins, W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 360 - 360
  • [27] How to evaluate adherence in haemophilia patients
    Von Mackensen, S.
    HAEMOPHILIA, 2014, 20 : 82 - 83
  • [28] Evaluation of adherence to prophylaxis treatment in haemophilia: Are we achieving our goal?
    Rocha, D. M. D. C.
    Duarte, J. S. M.
    Neto, A. Rocha
    Orletti, M. D. P. S. V.
    Santos, G. A. L. D.
    Liparizi, A.
    Calatrone, B. A.
    Prezotti, A. N. L.
    HAEMOPHILIA, 2024, 30 : 57 - 57
  • [29] Treatment of patients with haemophilia and the patients' perspective
    Smit, C.
    STATE OF THE ART PRESENTATIONS, 2010, 5 (01): : 59 - 62
  • [30] Emicizumab prophylaxis in patients with haemophilia A with and without inhibitors
    Ebbert, Patrick T.
    Xavier, Frederico
    Seaman, Craig D.
    Ragni, Margaret V.
    HAEMOPHILIA, 2020, 26 (01) : 41 - 46